First Step Toward CRISPR Cure for Lou Gehrig’s Disease

News   Jan 03, 2018 | Original story from UC Berkeley

 
First Step Toward CRISPR Cure for Lou Gehrig’s Disease

A cross-section of mouse spinal cord tissue showing cells in which the CRISPR-Cas9 gene has been expressed (green). The Cas9 gene has been successfully inserted into motor neurons (yellow), rescuing them from death, but not the support cells called astrocytes (red). Credit: David Schaffer

 
 
 

RELATED ARTICLES

Fragile X: Drug Strategy Could Alleviate Behavioral & Cellular Deficiencies

News

Research in mice shows that a pharmacological strategy can alleviate multiple behavioral and cellular deficiencies in a mouse model of fragile X syndrome (FXS), the most common inherited form of intellectual disability and a major single-gene cause of autism spectrum disorders.

READ MORE

Mouse Study Suggests That Dietary Fat, Not Carbs, Drives Obesity

News

A mouse study that made over 100,000 measurements of body weight and fat has concluded that the sole driver of obesity in mice is increased dietary fat content.

READ MORE

VIP Neuron Firing Rate Determines How Well You Overcome Jetlag

News

Testing the different firing patterns of VIP neurons, researchers found that mice got over jet lag faster when VIP neurons were activated to irregularly fire.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cell Science Drug Discovery Genomics Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy